SIMIELE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1744
EU - Europa 1273
AS - Asia 783
AF - Africa 53
SA - Sud America 35
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3926
Nazione #
US - Stati Uniti d'America 1691
DE - Germania 526
CN - Cina 361
IT - Italia 330
IN - India 142
GB - Regno Unito 70
JP - Giappone 57
FR - Francia 54
ID - Indonesia 44
VN - Vietnam 44
RU - Federazione Russa 41
CA - Canada 35
AU - Australia 32
NL - Olanda 29
CZ - Repubblica Ceca 28
KR - Corea 28
ES - Italia 26
AT - Austria 21
PL - Polonia 20
ZA - Sudafrica 18
MX - Messico 16
SE - Svezia 16
TH - Thailandia 16
TR - Turchia 16
UA - Ucraina 15
BE - Belgio 14
HK - Hong Kong 14
PK - Pakistan 13
BR - Brasile 12
RO - Romania 12
TW - Taiwan 12
EG - Egitto 11
IR - Iran 10
CH - Svizzera 9
HR - Croazia 9
NG - Nigeria 8
RS - Serbia 7
AR - Argentina 6
CO - Colombia 6
HU - Ungheria 6
LT - Lituania 6
DK - Danimarca 5
GR - Grecia 5
IE - Irlanda 5
IL - Israele 5
CL - Cile 4
FI - Finlandia 4
MY - Malesia 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
KE - Kenya 3
PH - Filippine 3
SG - Singapore 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZW - Zimbabwe 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
JO - Giordania 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CY - Cipro 1
JE - Jersey 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
SA - Arabia Saudita 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3926
Città #
Fairfield 210
Houston 183
Woodbridge 146
Torino 129
Seattle 116
Ashburn 99
Buffalo 93
Ann Arbor 90
Santa Cruz 90
Cambridge 82
Wilmington 74
Beijing 70
Leawood 55
Nürnberg 48
San Diego 34
Jinan 33
University Park 30
Dong Ket 26
Nanjing 22
Shanghai 21
Jakarta 20
Wuhan 19
Hangzhou 17
Guangzhou 16
Hebei 16
Shenyang 16
Changsha 14
Mountain View 13
Warsaw 13
Gurgaon 12
Ottawa 12
Las Vegas 11
Pisa 11
Hyderabad 10
Paris 10
Phoenix 10
Rome 10
Tettnang 10
Chicago 9
Dallas 9
Haikou 9
New Delhi 9
Tokyo 9
Bengaluru 8
Chengdu 8
Hanoi 8
Landshut 8
Taipei 8
Tianjin 8
Bangalore 7
Bangkok 7
Central 7
Clearwater 7
Istanbul 7
Lanzhou 7
Milan 7
Council Bluffs 6
Cuneo 6
Düsseldorf 6
Jiaxing 6
Lake Forest 6
London 6
Louvain 6
Lucknow 6
Muizenberg 6
Mumbai 6
Ningbo 6
Osaka 6
Szeged 6
Taiyuan 6
Buenos Aires 5
Cagliari 5
Ceska 5
Durban 5
Durham 5
Fuzhou 5
Kiel 5
Los Angeles 5
Riva 5
Taizhou 5
Toronto 5
Central District 4
Florange 4
Göteborg 4
Hamburg 4
Kumar 4
Lima 4
Nanchang 4
Napoli 4
Omaha 4
Oxford 4
Saint Petersburg 4
Scranton 4
Verona 4
Vicenza 4
Yokosuka 4
Zhengzhou 4
Amsterdam 3
Austin 3
Belgrade 3
Totale 2245
Nome #
Cannabis FM2: optimization and standardization of galenic preparations., file e27ce42e-b157-2581-e053-d805fe0acbaa 775
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma., file e27ce426-fc6b-2581-e053-d805fe0acbaa 443
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce426-eda7-2581-e053-d805fe0acbaa 437
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce427-c7f3-2581-e053-d805fe0acbaa 307
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment., file e27ce426-edaf-2581-e053-d805fe0acbaa 280
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2”, file e27ce42e-b155-2581-e053-d805fe0acbaa 231
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce426-fdb2-2581-e053-d805fe0acbaa 178
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors., file e27ce42a-3e63-2581-e053-d805fe0acbaa 168
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations., file e27ce426-dd32-2581-e053-d805fe0acbaa 144
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells., file e27ce42a-2054-2581-e053-d805fe0acbaa 143
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients., file e27ce426-f675-2581-e053-d805fe0acbaa 116
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes, file e27ce42e-7b55-2581-e053-d805fe0acbaa 115
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a7-2581-e053-d805fe0acbaa 109
Impact of Different Procedures of Galenic Formulations of Cannabis on Cannabinoids Contents, file e27ce42e-813d-2581-e053-d805fe0acbaa 109
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa 86
Raltegravir penetration in seminal plasma of healthy volunteers., file e27ce426-cc1e-2581-e053-d805fe0acbaa 56
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage., file e27ce426-d682-2581-e053-d805fe0acbaa 56
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce42a-686a-2581-e053-d805fe0acbaa 48
Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability, file e27ce431-6848-2581-e053-d805fe0acbaa 44
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b2bb-2581-e053-d805fe0acbaa 40
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce42a-5667-2581-e053-d805fe0acbaa 39
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce42a-40fa-2581-e053-d805fe0acbaa 29
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy, file e27ce435-5bc4-2581-e053-d805fe0acbaa 28
MONITORING OF VIROLOGICAL AND PHARMACOLOGICAL CEREBROSPINAL FLUID PARAMETERS IN HAART-TREATED HIV-POSITIVE PATIENTS IN THE CLINICAL SETTING, file e27ce426-d012-2581-e053-d805fe0acbaa 22
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce426-eb1c-2581-e053-d805fe0acbaa 11
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b616-2581-e053-d805fe0acbaa 9
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce428-c2c0-2581-e053-d805fe0acbaa 6
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia, file e27ce428-c622-2581-e053-d805fe0acbaa 6
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients, file e27ce42c-9b03-2581-e053-d805fe0acbaa 5
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce428-ca8b-2581-e053-d805fe0acbaa 4
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma, file e27ce42b-ee07-2581-e053-d805fe0acbaa 4
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir., file e27ce432-2134-2581-e053-d805fe0acbaa 4
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce433-9ce4-2581-e053-d805fe0acbaa 4
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients, file e27ce426-fbb6-2581-e053-d805fe0acbaa 3
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce426-edae-2581-e053-d805fe0acbaa 2
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines, file e27ce428-b8e7-2581-e053-d805fe0acbaa 2
Efavirenz pharmacogenetics in a cohort of Italian patients, file e27ce428-bc10-2581-e053-d805fe0acbaa 2
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens., file e27ce428-c7de-2581-e053-d805fe0acbaa 2
QUALITATIVE AND QUANTITATIVE EVALUATION OF DIFFERENT PHARMACEUTICAL PRODUCTS CONTAINING QUETIAPINE: BRAND VERSUS GENERIC, file e27ce42a-ae8b-2581-e053-d805fe0acbaa 2
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce42a-c0ee-2581-e053-d805fe0acbaa 2
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce42a-ee0b-2581-e053-d805fe0acbaa 2
Cannabinoids concentration variability in cannabis olive oil galenic preparations, file e27ce42c-9627-2581-e053-d805fe0acbaa 2
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients, file e27ce42c-987e-2581-e053-d805fe0acbaa 2
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce432-0d6d-2581-e053-d805fe0acbaa 2
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma, file e27ce426-fea8-2581-e053-d805fe0acbaa 1
Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole, file e27ce428-b63c-2581-e053-d805fe0acbaa 1
Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification, file e27ce428-b63f-2581-e053-d805fe0acbaa 1
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi., file e27ce428-b6aa-2581-e053-d805fe0acbaa 1
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce428-baf0-2581-e053-d805fe0acbaa 1
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce428-c0b7-2581-e053-d805fe0acbaa 1
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots., file e27ce428-c2dc-2581-e053-d805fe0acbaa 1
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce428-c358-2581-e053-d805fe0acbaa 1
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a6-2581-e053-d805fe0acbaa 1
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce42b-f4a4-2581-e053-d805fe0acbaa 1
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots, file e27ce42b-f4a8-2581-e053-d805fe0acbaa 1
A LC-MS method to quantify tenofovir urinary concentrations in treated patients, file e27ce431-c024-2581-e053-d805fe0acbaa 1
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting., file e27ce431-cdd1-2581-e053-d805fe0acbaa 1
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma., file e27ce431-e3a9-2581-e053-d805fe0acbaa 1
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions., file e27ce431-e3ab-2581-e053-d805fe0acbaa 1
An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients, file e27ce431-e478-2581-e053-d805fe0acbaa 1
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients., file e27ce431-e479-2581-e053-d805fe0acbaa 1
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices., file e27ce431-eb75-2581-e053-d805fe0acbaa 1
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes., file e27ce432-0dc8-2581-e053-d805fe0acbaa 1
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism., file e27ce432-1daf-2581-e053-d805fe0acbaa 1
Totale 4099
Categoria #
all - tutte 4675
article - articoli 0
book - libri 0
conference - conferenze 1391
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018165 0000 019 2918 32182227
2018/2019465 20271526 1515 1837 285911194
2019/2020964 614232109 9050 7976 902116064
2020/2021900 72654873 6786 8179 621018878
2021/2022915 966865111 8634 7756 543914188
2022/2023292 656013631 00 00 0000
Totale 4099